Perioral Dermatitis Treatment - Global and China Top Players Market Share and Ranking 2024
Perioral dermatitis is a type of rash which affects the area around the mouth and causes inflammation. The rash will extend up the nose or even into the eyes. The common symptom of this condition is a scaly or red bumpy rash. Lesions on darker skin can be hyperpigmented or brown. Antibiotics can be advantageous for a few weeks, whether oral or topically. Azelaic acid is a prescription-only topical medication. When treatment is disturbed, the problem may reoccur, but the same therapy can be restarted as needed.
This report studies and analyses global Perioral Dermatitis Treatment status and future trends, helps the client to determine the Perioral Dermatitis Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Perioral Dermatitis Treatment, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Perioral Dermatitis Treatment market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Perioral Dermatitis Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Perioral Dermatitis Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Perioral Dermatitis Treatment key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Perioral Dermatitis Treatment key producing regions, capacity, production, and year over year growth
(6) Perioral Dermatitis Treatment industry chains, upstream, midstream and downstream
According to latest study, the global market for Perioral Dermatitis Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Perioral Dermatitis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Perioral Dermatitis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Retail Pharmacy grew percent to account for percent of the total market sales, and Online Pharmacies grew percent.
Market segment by players, this report covers
Novartis AG
AstraZeneca
Merck & Co., Inc
Sumitomo Corporation
LEO Pharma A/S
Cipla Inc
Lilly
Bayer AG
Abbott
Pfizer Inc
GSK plc
Johnson & Johnson Private Limited
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Lupin
Bausch Health Companies Inc
F. Hoffmann-La Roche Ltd
Mylan N.V
Market segment by Type, covers
Oral
Injection
External Use
Market segment by Application, can be divided into
Retail Pharmacy
Online Pharmacies
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Perioral Dermatitis Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Perioral Dermatitis Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Perioral Dermatitis Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Perioral Dermatitis Treatment, percent & CAGR, 2018-2029
Chapter 5: Perioral Dermatitis Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Perioral Dermatitis Treatment Definition
1.2 Global Perioral Dermatitis Treatment Market Size and Forecast
1.2.1 By Consumption Value, Global Perioral Dermatitis Treatment Market Size，2018-2029
1.2.2 By Sales Quantity, Global Perioral Dermatitis Treatment Market Size，2018-2029
1.2.3 Global Perioral Dermatitis Treatment Average Selling Price (ASP)，2018-2029
1.3 China Perioral Dermatitis Treatment Market Size and Forecast
1.3.1 By Consumption Value, China Perioral Dermatitis Treatment Market Size，2018-2029
1.3.2 By Sales Quantity, China Perioral Dermatitis Treatment Market Size，2018-2029
1.3.3 China Perioral Dermatitis Treatment Average Selling Price (ASP)， 2018-2029
1.4 Share of China Perioral Dermatitis Treatment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Perioral Dermatitis Treatment Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Perioral Dermatitis Treatment Market Share in Global, 2018-2029
1.4.3 Perioral Dermatitis Treatment Market Size: China VS Global, 2018-2029
1.5 Perioral Dermatitis Treatment Market Dynamics
1.5.1 Perioral Dermatitis Treatment Market Drivers
1.5.2 Perioral Dermatitis Treatment Market Restraints
1.5.3 Perioral Dermatitis Treatment Industry Trends
1.5.4 Perioral Dermatitis Treatment Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Perioral Dermatitis Treatment, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Perioral Dermatitis Treatment, Global Market Share by Company, 2018-2023
2.3 Perioral Dermatitis Treatment Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Perioral Dermatitis Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Perioral Dermatitis Treatment Concentration Ratio
2.6 Global Perioral Dermatitis Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Perioral Dermatitis Treatment Manufacturers Product Type
2.8 Head Office and Perioral Dermatitis Treatment Production Site of Key Manufacturer
2.9 Perioral Dermatitis Treatment Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Perioral Dermatitis Treatment, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Perioral Dermatitis Treatment, China Market Share by Company, 2018-2023
3.3 China Perioral Dermatitis Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Perioral Dermatitis Treatment Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Perioral Dermatitis Treatment Capacity by Region
4.3 Global Perioral Dermatitis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Perioral Dermatitis Treatment Production by Region, 2018-2029
4.5 Global Perioral Dermatitis Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Perioral Dermatitis Treatment Industry Chain
5.2 Perioral Dermatitis Treatment Upstream Analysis
5.2.1 Perioral Dermatitis Treatment Core Raw Materials
5.2.2 Main Manufacturers of Perioral Dermatitis Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Perioral Dermatitis Treatment Production Mode
5.6 Perioral Dermatitis Treatment Procurement Model
5.7 Perioral Dermatitis Treatment Industry Sales Model and Sales Channels
5.7.1 Perioral Dermatitis Treatment Sales Model
5.7.2 Perioral Dermatitis Treatment Typical Distributors
6 Sights by Type
6.1 Perioral Dermatitis Treatment Classification
6.1.1 Oral
6.1.2 Injection
6.1.3 External Use
6.2 By Type, Global Perioral Dermatitis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029
6.4 By Type, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029
6.5 By Type, Global Perioral Dermatitis Treatment Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Perioral Dermatitis Treatment Segment by Application
7.1.1 Retail Pharmacy
7.1.2 Online Pharmacies
7.1.3 Other
7.2 By Application, Global Perioral Dermatitis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029
7.4 By Application, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029
7.5 By Application, Global Perioral Dermatitis Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Perioral Dermatitis Treatment Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029
8.3 By Region, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Perioral Dermatitis Treatment & Forecasts, 2018-2029
8.4.2 By Country, North America Perioral Dermatitis Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Perioral Dermatitis Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Perioral Dermatitis Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Perioral Dermatitis Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Perioral Dermatitis Treatment Market Size Market Share
8.7 South America
8.7.1 South America Perioral Dermatitis Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Perioral Dermatitis Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Perioral Dermatitis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029
9.3 By Country, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Perioral Dermatitis Treatment Market Size, 2018-2029
9.4.2 By Type, U.S. Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Perioral Dermatitis Treatment Market Size, 2018-2029
9.5.2 By Type, Europe Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Perioral Dermatitis Treatment Market Size, 2018-2029
9.6.2 By Type, China Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Perioral Dermatitis Treatment Market Size, 2018-2029
9.7.2 By Type, Japan Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Perioral Dermatitis Treatment Market Size, 2018-2029
9.8.2 By Type, South Korea Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Perioral Dermatitis Treatment Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Perioral Dermatitis Treatment Market Size, 2018-2029
9.10.2 By Type, India Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Perioral Dermatitis Treatment Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis AG
10.1.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novartis AG Perioral Dermatitis Treatment Models, Specifications, and Application
10.1.3 Novartis AG Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis AG Company Profile and Main Business
10.1.5 Novartis AG Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.2.2 AstraZeneca Perioral Dermatitis Treatment Models, Specifications, and Application
10.2.3 AstraZeneca Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 AstraZeneca Company Profile and Main Business
10.2.5 AstraZeneca Recent Developments
10.3 Merck & Co., Inc
10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.3.2 Merck & Co., Inc Perioral Dermatitis Treatment Models, Specifications, and Application
10.3.3 Merck & Co., Inc Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck & Co., Inc Company Profile and Main Business
10.3.5 Merck & Co., Inc Recent Developments
10.4 Sumitomo Corporation
10.4.1 Sumitomo Corporation Company Information, Head Office, Market Area, and Industry Position
10.4.2 Sumitomo Corporation Perioral Dermatitis Treatment Models, Specifications, and Application
10.4.3 Sumitomo Corporation Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Sumitomo Corporation Company Profile and Main Business
10.4.5 Sumitomo Corporation Recent Developments
10.5 LEO Pharma A/S
10.5.1 LEO Pharma A/S Company Information, Head Office, Market Area, and Industry Position
10.5.2 LEO Pharma A/S Perioral Dermatitis Treatment Models, Specifications, and Application
10.5.3 LEO Pharma A/S Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 LEO Pharma A/S Company Profile and Main Business
10.5.5 LEO Pharma A/S Recent Developments
10.6 Cipla Inc
10.6.1 Cipla Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Cipla Inc Perioral Dermatitis Treatment Models, Specifications, and Application
10.6.3 Cipla Inc Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Cipla Inc Company Profile and Main Business
10.6.5 Cipla Inc Recent Developments
10.7 Lilly
10.7.1 Lilly Company Information, Head Office, Market Area, and Industry Position
10.7.2 Lilly Perioral Dermatitis Treatment Models, Specifications, and Application
10.7.3 Lilly Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Lilly Company Profile and Main Business
10.7.5 Lilly Recent Developments
10.8 Bayer AG
10.8.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position
10.8.2 Bayer AG Perioral Dermatitis Treatment Models, Specifications, and Application
10.8.3 Bayer AG Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bayer AG Company Profile and Main Business
10.8.5 Bayer AG Recent Developments
10.9 Abbott
10.9.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.9.2 Abbott Perioral Dermatitis Treatment Models, Specifications, and Application
10.9.3 Abbott Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Abbott Company Profile and Main Business
10.9.5 Abbott Recent Developments
10.10 Pfizer Inc
10.10.1 Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
10.10.2 Pfizer Inc Perioral Dermatitis Treatment Models, Specifications, and Application
10.10.3 Pfizer Inc Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Pfizer Inc Company Profile and Main Business
10.10.5 Pfizer Inc Recent Developments
10.11 GSK plc
10.11.1 GSK plc Company Information, Head Office, Market Area, and Industry Position
10.11.2 GSK plc Perioral Dermatitis Treatment Models, Specifications, and Application
10.11.3 GSK plc Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 GSK plc Company Profile and Main Business
10.11.5 GSK plc Recent Developments
10.12 Johnson & Johnson Private Limited
10.12.1 Johnson & Johnson Private Limited Company Information, Head Office, Market Area, and Industry Position
10.12.2 Johnson & Johnson Private Limited Perioral Dermatitis Treatment Models, Specifications, and Application
10.12.3 Johnson & Johnson Private Limited Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Johnson & Johnson Private Limited Company Profile and Main Business
10.12.5 Johnson & Johnson Private Limited Recent Developments
10.13 Teva Pharmaceutical Industries Ltd
10.13.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.13.2 Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications, and Application
10.13.3 Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.13.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.14 Sun Pharmaceutical Industries Ltd
10.14.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.14.2 Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications, and Application
10.14.3 Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.14.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.15 Aurobindo Pharma
10.15.1 Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position
10.15.2 Aurobindo Pharma Perioral Dermatitis Treatment Models, Specifications, and Application
10.15.3 Aurobindo Pharma Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Aurobindo Pharma Company Profile and Main Business
10.15.5 Aurobindo Pharma Recent Developments
10.16 Lupin
10.16.1 Lupin Company Information, Head Office, Market Area, and Industry Position
10.16.2 Lupin Perioral Dermatitis Treatment Models, Specifications, and Application
10.16.3 Lupin Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Lupin Company Profile and Main Business
10.16.5 Lupin Recent Developments
10.17 Bausch Health Companies Inc
10.17.1 Bausch Health Companies Inc Company Information, Head Office, Market Area, and Industry Position
10.17.2 Bausch Health Companies Inc Perioral Dermatitis Treatment Models, Specifications, and Application
10.17.3 Bausch Health Companies Inc Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Bausch Health Companies Inc Company Profile and Main Business
10.17.5 Bausch Health Companies Inc Recent Developments
10.18 F. Hoffmann-La Roche Ltd
10.18.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.18.2 F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Models, Specifications, and Application
10.18.3 F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.18.5 F. Hoffmann-La Roche Ltd Recent Developments
10.19 Mylan N.V
10.19.1 Mylan N.V Company Information, Head Office, Market Area, and Industry Position
10.19.2 Mylan N.V Perioral Dermatitis Treatment Models, Specifications, and Application
10.19.3 Mylan N.V Perioral Dermatitis Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Mylan N.V Company Profile and Main Business
10.19.5 Mylan N.V Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Perioral Dermatitis Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Perioral Dermatitis Treatment Market Restraints
Table 3. Perioral Dermatitis Treatment Market Trends
Table 4. Perioral Dermatitis Treatment Industry Policy
Table 5. Global Perioral Dermatitis Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Perioral Dermatitis Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Perioral Dermatitis Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Perioral Dermatitis Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Perioral Dermatitis Treatment Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Perioral Dermatitis Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Perioral Dermatitis Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Perioral Dermatitis Treatment Manufacturers Product Type
Table 13. Head Office and Perioral Dermatitis Treatment Production Site of Key Manufacturer
Table 14. Perioral Dermatitis Treatment Capacity of Major Manufacturers and Future Plan
Table 15. China Perioral Dermatitis Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Perioral Dermatitis Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Perioral Dermatitis Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Perioral Dermatitis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Perioral Dermatitis Treatment Production by Region, 2018-2023, (K Units)
Table 20. Global Perioral Dermatitis Treatment Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Perioral Dermatitis Treatment Upstream (Raw Materials)
Table 22. Global Perioral Dermatitis Treatment Typical Customers
Table 23. Perioral Dermatitis Treatment Typical Distributors
Table 24. By Type, Global Perioral Dermatitis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Perioral Dermatitis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Perioral Dermatitis Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Perioral Dermatitis Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Perioral Dermatitis Treatment Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Perioral Dermatitis Treatment Sales Quantity Market Share, 2018-2029
Table 34. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 35. Novartis AG Perioral Dermatitis Treatment Models, Specifications, and Application
Table 36. Novartis AG Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Novartis AG Company Profile and Main Business
Table 38. Novartis AG Recent Developments
Table 39. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 40. AstraZeneca Perioral Dermatitis Treatment Models, Specifications, and Application
Table 41. AstraZeneca Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. AstraZeneca Company Profile and Main Business
Table 43. AstraZeneca Recent Developments
Table 44. Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
Table 45. Merck & Co., Inc Perioral Dermatitis Treatment Models, Specifications, and Application
Table 46. Merck & Co., Inc Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck & Co., Inc Company Profile and Main Business
Table 48. Merck & Co., Inc Recent Developments
Table 49. Sumitomo Corporation Company Information, Head Office, Market Area, and Industry Position
Table 50. Sumitomo Corporation Perioral Dermatitis Treatment Models, Specifications, and Application
Table 51. Sumitomo Corporation Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Sumitomo Corporation Company Profile and Main Business
Table 53. Sumitomo Corporation Recent Developments
Table 54. LEO Pharma A/S Company Information, Head Office, Market Area, and Industry Position
Table 55. LEO Pharma A/S Perioral Dermatitis Treatment Models, Specifications, and Application
Table 56. LEO Pharma A/S Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. LEO Pharma A/S Company Profile and Main Business
Table 58. LEO Pharma A/S Recent Developments
Table 59. Cipla Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Cipla Inc Perioral Dermatitis Treatment Models, Specifications, and Application
Table 61. Cipla Inc Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Cipla Inc Company Profile and Main Business
Table 63. Cipla Inc Recent Developments
Table 64. Lilly Company Information, Head Office, Market Area, and Industry Position
Table 65. Lilly Perioral Dermatitis Treatment Models, Specifications, and Application
Table 66. Lilly Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Lilly Company Profile and Main Business
Table 68. Lilly Recent Developments
Table 69. Bayer AG Company Information, Head Office, Market Area, and Industry Position
Table 70. Bayer AG Perioral Dermatitis Treatment Models, Specifications, and Application
Table 71. Bayer AG Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Bayer AG Company Profile and Main Business
Table 73. Bayer AG Recent Developments
Table 74. Abbott Company Information, Head Office, Market Area, and Industry Position
Table 75. Abbott Perioral Dermatitis Treatment Models, Specifications, and Application
Table 76. Abbott Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Abbott Company Profile and Main Business
Table 78. Abbott Recent Developments
Table 79. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
Table 80. Pfizer Inc Perioral Dermatitis Treatment Models, Specifications, and Application
Table 81. Pfizer Inc Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Pfizer Inc Company Profile and Main Business
Table 83. Pfizer Inc Recent Developments
Table 84. GSK plc Company Information, Head Office, Market Area, and Industry Position
Table 85. GSK plc Perioral Dermatitis Treatment Models, Specifications, and Application
Table 86. GSK plc Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. GSK plc Company Profile and Main Business
Table 88. GSK plc Recent Developments
Table 89. Johnson & Johnson Private Limited Company Information, Head Office, Market Area, and Industry Position
Table 90. Johnson & Johnson Private Limited Perioral Dermatitis Treatment Models, Specifications, and Application
Table 91. Johnson & Johnson Private Limited Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Johnson & Johnson Private Limited Company Profile and Main Business
Table 93. Johnson & Johnson Private Limited Recent Developments
Table 94. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 95. Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications, and Application
Table 96. Teva Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 98. Teva Pharmaceutical Industries Ltd Recent Developments
Table 99. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 100. Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Models, Specifications, and Application
Table 101. Sun Pharmaceutical Industries Ltd Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 103. Sun Pharmaceutical Industries Ltd Recent Developments
Table 104. Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position
Table 105. Aurobindo Pharma Perioral Dermatitis Treatment Models, Specifications, and Application
Table 106. Aurobindo Pharma Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Aurobindo Pharma Company Profile and Main Business
Table 108. Aurobindo Pharma Recent Developments
Table 109. Lupin Company Information, Head Office, Market Area, and Industry Position
Table 110. Lupin Perioral Dermatitis Treatment Models, Specifications, and Application
Table 111. Lupin Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Lupin Company Profile and Main Business
Table 113. Lupin Recent Developments
Table 114. Bausch Health Companies Inc Company Information, Head Office, Market Area, and Industry Position
Table 115. Bausch Health Companies Inc Perioral Dermatitis Treatment Models, Specifications, and Application
Table 116. Bausch Health Companies Inc Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Bausch Health Companies Inc Company Profile and Main Business
Table 118. Bausch Health Companies Inc Recent Developments
Table 119. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
Table 120. F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Models, Specifications, and Application
Table 121. F. Hoffmann-La Roche Ltd Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 123. F. Hoffmann-La Roche Ltd Recent Developments
Table 124. Mylan N.V Company Information, Head Office, Market Area, and Industry Position
Table 125. Mylan N.V Perioral Dermatitis Treatment Models, Specifications, and Application
Table 126. Mylan N.V Perioral Dermatitis Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Mylan N.V Company Profile and Main Business
Table 128. Mylan N.V Recent Developments
List of Figures
Figure 1. Perioral Dermatitis Treatment Picture
Figure 2. Global Perioral Dermatitis Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Perioral Dermatitis Treatment Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Perioral Dermatitis Treatment Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Perioral Dermatitis Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Perioral Dermatitis Treatment Sales Quantity (K Units) & (2018-2029)
Figure 7. China Perioral Dermatitis Treatment Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Perioral Dermatitis Treatment Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Perioral Dermatitis Treatment Market Share of Global, 2018-2029
Figure 10. Global Perioral Dermatitis Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Perioral Dermatitis Treatment Key Participants, Market Share, 2022
Figure 12. Global Perioral Dermatitis Treatment Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Perioral Dermatitis Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Perioral Dermatitis Treatment Production Market Share & Forecast by Region, 2018-2029
Figure 15. Perioral Dermatitis Treatment Industry Chain
Figure 16. Perioral Dermatitis Treatment Procurement Model
Figure 17. Perioral Dermatitis Treatment Sales Model
Figure 18. Perioral Dermatitis Treatment Sales Channels, Direct Sales, and Distribution
Figure 19. Oral
Figure 20. Injection
Figure 21. External Use
Figure 22. By Type, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Perioral Dermatitis Treatment Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Perioral Dermatitis Treatment Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Perioral Dermatitis Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Retail Pharmacy
Figure 28. Online Pharmacies
Figure 29. Other
Figure 30. By Application, Global Perioral Dermatitis Treatment Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Perioral Dermatitis Treatment Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Perioral Dermatitis Treatment Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Perioral Dermatitis Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Perioral Dermatitis Treatment Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Perioral Dermatitis Treatment Sales Quantity Market Share, 2018-2029
Figure 37. North America Perioral Dermatitis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Perioral Dermatitis Treatment Consumption Value Market Share, 2022
Figure 39. Europe Perioral Dermatitis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Perioral Dermatitis Treatment Consumption Value Market Share, 2022
Figure 41. Asia Pacific Perioral Dermatitis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Perioral Dermatitis Treatment Consumption Value Market Share, 2022
Figure 43. South America Perioral Dermatitis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Perioral Dermatitis Treatment Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Perioral Dermatitis Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Perioral Dermatitis Treatment Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Perioral Dermatitis Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|